Figure 7
Figure 7. Susceptibility to DSS-induced colitis. (A) Colonoscopy scores of WT mice, CX3CR1−/− mice, CX3CL1−/− mice, CX3CL1395AA:CX3CL1−/− mice, and CX3CL1105Δ:CX3CL1−/− mice after indicated DSS challenge (day 7). (B) Representative colonoscopy images taken from mice at day 7. (C) Change of colonoscopy scores between day 7 and day 10. (D) ELISA of serum of WT mice, CX3CR1−/− mice, CX3CL1−/− mice, CX3CL1395AA:CX3CL1−/− mice, and CX3CL1105Δ:CX3CL1−/− mice after indicated DSS challenge for IL-6 (day 10). Results are one representative of 2 independent experiments (N = 5-7). *P < .05 (1-way ANOVA followed by Bonferroni Multiple Comparison). ***P < .001 (1-way ANOVA followed by Bonferroni Multiple Comparison).

Susceptibility to DSS-induced colitis. (A) Colonoscopy scores of WT mice, CX3CR1−/− mice, CX3CL1−/− mice, CX3CL1395AA:CX3CL1−/− mice, and CX3CL1105Δ:CX3CL1−/− mice after indicated DSS challenge (day 7). (B) Representative colonoscopy images taken from mice at day 7. (C) Change of colonoscopy scores between day 7 and day 10. (D) ELISA of serum of WT mice, CX3CR1−/− mice, CX3CL1−/− mice, CX3CL1395AA:CX3CL1−/− mice, and CX3CL1105Δ:CX3CL1−/− mice after indicated DSS challenge for IL-6 (day 10). Results are one representative of 2 independent experiments (N = 5-7). *P < .05 (1-way ANOVA followed by Bonferroni Multiple Comparison). ***P < .001 (1-way ANOVA followed by Bonferroni Multiple Comparison).

Close Modal

or Create an Account

Close Modal
Close Modal